DKSH to Acquire Taqkey, Quantum to Boost Life Science Reach in Asia-Pacific

DKSH has revealed that it has entered into an agreement to purchase Taqkey and Quantum, two companies that distribute life science reagents and consumables in Taiwan. The products supplied include reagents and consumables for molecular biology, gene engineering, and cell therapies. Hence, DKSH Technology solidifies its regional footprint in the life science sector across Asia-Pacific.

Established in 2002, Taqkey is based in Miaoli, Taiwan. In collaboration with Quantum, the organization has a workforce exceeding 60 individuals and achieves annual net sales surpassing CHF 13 million1, maintaining strong profitability while relying on established, successful partnerships with well-known blue-chip clients in the life science sector. The Group runs seven sales offices and three storage facilities throughout Taiwan.

Hanno Elbraechter, Head – Business Unit Technology, DKSH, said, “With Taqkey, we will further grow our consumables business in the life science industry of Asia-Pacific and thus solidify our position as a leading scientific solutions provider in the region. We are delighted to jointly leverage Taqkey’s attractive client and customer portfolio and the synergies created by our joint operations.” 

Jeffrey Cheung, Founder and Managing Director, Taqkey, commented, “We are excited about our  shared future with DKSH, a leading technology solutions provider in Asia Pacific. As DKSH will benefit from our longstanding client and customer relationships in Taiwan, we will be happy to leverage DKSH’s broad expertise and use existing sales channels to further grow our business. We are confident this step will positively impact all our business partners as well as our valued employees.” 

The completion of the deal is anticipated in the second quarter of 2025 and is subject to specific conditions.